License-out buzz lifts STCube, Ildong Holdings, Toolgen[K-Bio Pulse] 유진희 2025.11.07 오전 10:37 Cellbion Reports Positive Phase 2 Results in Prostate Cancer Therapy 유진희 2025.09.04 오후 06:00 Wonik Soars on Policy Tailwinds; Y2Solution Gains on Licensing Buzz[K-Bio Pulse] 유진희 2025.06.05 오전 09:10 From Corestem to Yuhan: Cellbion Eyes Fast-Track Path for Lu-177-DGUL 유진희 2025.08.27 오전 08:27 DXVX Soars on First License-Out DealNature Cell[K-Bio Pulse] 유진희 2025.07.31 오전 09:00 Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties 유진희 2025.09.05 오전 08:30 Biopharma Earnings Drive Undervalued Stocks Higher, L&C Bio Extends Rally[K-Bio Pulse] 유진희 2025.09.09 오전 09:30 Sellbion CEO Kwon Kim: “Maximizing the Power of 177Lu-DGUL Immuno-Oncology Combo” 유진희 2025.07.21 오전 09:30 Cellbion Starts Merck Trial, Targets Global Sales and Licensing 유진희 2025.06.05 오전 10:53 AdBiotech and HK Inno.N Surge on Future Value Hopes[K-Bio Pulse] 유진희 2025.06.10 오전 08:12 더 보기 로딩중..
Phamedaily
Phamedaily
![License-out buzz lifts STCube, Ildong Holdings, Toolgen[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25110700877b.jpg)
![Wonik Soars on Policy Tailwinds; Y2Solution Gains on Licensing Buzz[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/06/PS25060500525b.jpg)
![DXVX Soars on First License-Out DealNature Cell[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/07/PS25073100552b.jpg)
![Biopharma Earnings Drive Undervalued Stocks Higher, L&C Bio Extends Rally[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/09/PS25091400101b.jpg)
![AdBiotech and HK Inno.N Surge on Future Value Hopes[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/06/PS25061000260b.jpg)